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The phenotypic and genetic characteristics of spirochetes isolated from the blood of one U.S. and six French
patients with severe clinical disease or impaired immunity were examined. All spirochetes were anaerobic,
weakly b-hemolytic, positive for hippurate hydrolysis, and negative for b-glucosidase activity. Cell lengths
ranged from 4 to 8 mm, and each isolate had between 8 and 12 periplasmic ﬂagella per cell. These features were
consistent with the spirochetes’ being Serpulina pilosicoli, the agent of intestinal spirochetosis. All isolates were
positive in a PCR assay amplifying a portion of the S. pilosicoli 16S rRNA gene, and they all grouped with fecal
isolates of S. pilosicoli in multilocus enzyme electrophoresis (MLEE). The blood isolates could be differentiated
from each other by MLEE, although the U.S. and two French isolates were closely related. Apparently S.
pilosicoli may translocate from the large intestine to establish spirochetemia. The clinical signiﬁcance of this
ﬁnding remains uncertain and requires further investigation.
Intestinal spirochetes of the genus Serpulina inhabit the
large intestines of humans and animals (15). A number of
reports have documented the isolation of morphologically sim-
ilar spirochetes in other organ systems of humans. Cholestatic
hepatitis due to invasion of the liver with spirochetes has been
reported for an AIDS patient (11), and spirochetes were iso-
lated from the stools and blood of a French patient with non-
obstructive cardiomyopathy who went into shock following
acute hemorrhagic diarrhea and later died from cardiac insuf-
ﬁciency (13). A more recent report documented the isolation
of spirochetes from the blood of six severely ill French patients
with a variety of clinical problems, including vascular disease,
malignancy, intoxication with ethylene glycol, and cecal necro-
sis (5). Four of the patients subsequently died. These spiro-
chetes were morphologically similar to those in the genus Ser-
pulina, and they were provisionally identiﬁed as Serpulina
hyodysenteriae, the agent of swine dysentery in pigs.
In the present study we examined the six isolates from
France, together with a spirochete isolated from the blood of a
patient in the United States, in order to establish their identi-
ties and relationships to each other. We examined some key
phenotypic traits of spirochetes in the genus Serpulina and then
performed a PCR test that is speciﬁc for Serpulina pilosicoli.
We then undertook multilocus enzyme electrophoresis
(MLEE) analysis to compare the strains with other known
intestinal isolates of S. pilosicoli from humans, a dog, and a pig.
S. pilosicoli is the etiological agent of porcine intestinal spiro-
chetosis, a diarrheal disease of growing pigs resulting in the
passage of watery to mucoid feces (23, 25). A pathognomonic
feature of the infection is the attachment of large numbers of
spirochetes by one cell end to the cecal or colonic epithelium.
S. pilosicoli also has been isolated from the feces of humans
with clinical signs and lesions suggestive of intestinal spirochet-
osis, most notably in individuals in developing communities
and in AIDS patients and homosexual males in Western soci-
eties (14, 15). The organism also naturally colonizes dogs and
birds, which may be reservoirs of human pathogens (2, 3).
Primary culture of the seven isolates from the bloodstream
was performed in anaerobic blood culture medium, with
growth observed by dark-ﬁeld microscopy. The ﬁrst six strains
were recovered from unrelated French patients (5). Strains
PE90 and BR 81/80 were isolated from patients who died
following a stroke; strain 28/94 was isolated from an alcoholic
who died from shock associated with complete jejunal necrosis
following ingestion of 1 liter of ethylene glycol. Strain RA/87
was recovered from a patient who died from severe arteriopa-
thy. The other two strains were obtained from patients with
severe clinical illness who later recovered following surgery
and/or therapy. Strain HJ 128/90 was isolated from a patient
with peritonitis (following necrosis of the cecum), and strain
382/91 was isolated from an alcoholic with myeloma. Primary
isolation was performed in Hemoline blood culture bottles
(bioMerieux, Lyon, France) or, for strain 382/91, in BioArgos
Sanoﬁ diagnostic anaerobic medium (Pasteur Institute, Paris,
France). The seventh strain, H1, was isolated from a Califor-
nian AIDS patient receiving chemotherapy for Kaposi’s sar-
coma. The patient presented with thrombophlebitis in the arm
used to infuse the chemotherapy. No growth signal was ob-
tained in the ESP automated blood culture system (Difco,
Detroit, Mich.), but the spirochete was observed by microscopy
and subsequently isolated from a subculture. No attempt to
isolate spirochetes from the feces of the patients was made,
although strains BR 81/80 and 382/91 were isolated from the
blood of patients with diarrhea.
In the identiﬁcation process, the human blood strains were
compared with the type strains of each of the three recognized
species of Serpulina: S. hyodysenteriae B78, Serpulina innocens
B256, and S. pilosicoli P43/6/78 (25). Additional strains for
comparison included S. pilosicoli WesB, isolated from an Ab-
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482original child with diarrhea (14), and porcine strains from two
proposed species: “Serpulina intermedius” PWS/A (ATCC
51140) (16) and “Serpulina murdochii” 56/150 (ATCC 51284)
(15). For MLEE, the results for the blood strains were com-
pared with previously published results obtained for 68 S. pi-
losicoli strains isolated from human feces in various areas of
the world, 1 S. pilosicoli strain isolated from the feces of a dog,
and S. pilosicoli type strain P43/6/78 (15). For identiﬁcation,
each isolate was grown on Trypticase soy agar (Becton Dick-
inson, Cockeysville, Md.), supplemented with 5% deﬁbrinated
ovine blood, under an atmosphere of 94% H2 and 6% CO2.
After growth for 3 to 5 days at 378C, the strength of b-hemo-
lysis around individual colonies was compared with that for
type strains B78 (strong hemolysis) and B256 (weak hemoly-
sis). Indole production was assessed by extracting 2 ml of each
active 72-h culture grown in Kunkle’s medium (12) with 1 ml of
xylene and adding 4 drops of Kova ￿cs reagent (16). The bio-
chemical activities of cells harvested from agar plates were
assessed with API ZYM (API, Montalieu-Vercieu, France),
and proﬁles were recorded as recommended for intestinal spi-
rochetes (10, 16). Hippurate hydrolysis was assessed by the
ninhydrin method, as described for intestinal spirochetes (4).
The lengths and number of periplasmic ﬂagella per cell har-
vested from agar were recorded with a Philips 301 transmission
electron microscope, as previously described for porcine spi-
rochetes (16). A speciﬁc PCR then was applied to all strains,
using S. pilosicoli-speciﬁc primers designed to amplify a
1,330-bp portion of the 16S rRNA gene (18). Whole cells were
washed and boiled for 10 min prior to PCR ampliﬁcation. The
product was detected by ethidium bromide staining following
electrophoresis in 1.5% agarose. The electrophoretic mobili-
ties of 15 constitutive enzymes were determined for the seven
blood spirochete strains by MLEE (16). Details of electro-
phoretic running conditions, buffers, and enzyme assays have
been given previously (15, 16). Allele proﬁles generated for the
seven strains were grouped into electrophoretic types (ETs)
which were compared with ETs generated for the other 70
strains previously examined (15). Genetic distance between
ETs was calculated as the proportion of ﬁxed loci at which
dissimilar alleles occurred. A phenogram illustrating genetic
distance between ETs was constructed as described previously
(Fig. 1) (16).
The results of the phenotypic tests are summarized in Table
1. The seven blood strains were all weakly hemolytic, positive
for hippurate hydrolysis, and negative for b-glucosidase activ-
ity in the API ZYM system. They were from 4 to 8 mm long and
had between 8 and 12 periplasmic ﬂagella per cell (4 to 6 at
each cell end). These phenotypic characteristics were shared by
S. pilosicoli WesB and P43/6/78
T. Three of the strains (RA/87,
HJ 128/90, and H1) were positive for indole production. A
PCR product of 1,330 bp was generated for each of the human
blood spirochetes and for S. pilosicoli P43/6/78
T and WesB but
not for any of the type strains of the other species of Serpulina.
In the MLEE analysis the 77 strains were divided into 50 ETs.
Three major divisions of ETs separated by a genetic distance of
0.32 were created. Each blood strain had a unique allele proﬁle
(ETs 14, 27, 36, 37, 38, 44, and 47 [depicted in Fig. 1 and listed
in Table 1]). Two of the blood strains were located in division
B, and ﬁve were located in division C. Strain H1 from the
United States (ET 36) and French strains BR 81/80 and 28/94
(ETs 37 and 38) were closely related, each being differentiated
from the others by single alleles.
The seven human blood spirochetes were identiﬁed as
strains of S. pilosicoli on the basis of their distinguishing phe-
notypic characteristics and their positive reaction in a speciﬁc
PCR assay. Hippurate hydrolysis, lack of b-glucosidase activity,
and number of periplasmic ﬂagella per cell (8 to 12) have been
used to identify strains of S. pilosicoli (24, 25). Interestingly,
three of the blood spirochete strains gave positive reactions for
indole production, a trait not previously reported for S. pilosi-
coli and usually possessed only by strains of S. hyodysenteriae
and the proposed species of weakly b-hemolytic spirochete
“Serpulina intermedius” (16). The results of MLEE also helped
conﬁrm the identities of the blood spirochetes. The two human
blood strains located in division B of the phenogram and the
other ﬁve strains in division C were separated from the type
strain of S. pilosicoli, P43/6/78 (assigned to ET 2 of division A),
by genetic distances of 0.30 and 0.32, respectively. In previous
FIG. 1. Phenogram illustrating genetic relationships among 50 ETs of S.
pilosicoli, including the porcine type strain of ET 2, a canine fecal strain of ET 26,
68 human fecal strains, and 7 strains isolated from human blood, indicated by
thick lines and listed in Table 1.
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homology with strain P43/6/78
T and 100% homology with
strain ATCC 49776 (3). In the present study, strain ATCC
49776, assigned here to ET 50, was separated from P43/6/78
T
by a genetic distance of 0.43. These close DNA-DNA reasso-
ciation values between isolates with relatively large MLEE
genetic distances between them help to conﬁrm that all strains
examined belonged to S. pilosicoli. The MLEE study also dem-
onstrated that while generally the blood isolates of S. pilosicoli
were genetically heterogeneous, the U.S. and two French iso-
lates were closely related and could be considered to represent
a clonal group. All the blood isolates were closely related to
fecal isolates which previously had been recovered in several
studies in different parts of the world (15); this suggests that
the blood isolates were likely to have originated in the intes-
tinal tract. Translocation of bacteria or endotoxin from the
intestine commonly occurs in debilitated patients as a result of
overgrowth of gram-negative bacteria, impaired host immune
defenses, or injury to the gut mucosa resulting in increased
mucosal permeability (6). It has been suggested that the pre-
dominant biotype or serotype in the gut will be the bacteria
most likely to translocate to other organ systems (6). Although
fecal culture for S. pilosicoli was not undertaken in any of the
cases described here, two patients were reported to have diar-
rhea. Previously, simultaneous culture of spirochetes resem-
bling S. (then Treponema) hyodysenteriae from the blood and
feces of a patient was recorded for a debilitated patient (13),
although unfortunately this organism is not available for fur-
ther characterization. The factors initiating translocation of S.
pilosicoli and the clinical signiﬁcance of this bacteremia remain
uncertain.
In most previous studies involving intestinal spirochetes in
humans, spirochetal cells were reported to be attached to the
epithelial brush border in biopsy sections, but no attempts to
culture the organisms to establish their identity were made
(19). Generally, these spirochetes have been assumed to be
Brachyspira aalborgi (9) and have been seen attached to host
epithelial cells, with little inﬂammation or penetration beyond
the host cell membrane. In some cases, however, spirochetes
have been observed within rectal epithelial cells, subepithelial
macrophages, and Schwann cells (1, 7), with an associated
increase in the number of immunoglobulin E-secreting plasma
cells in the lamina propria (7). They have also been observed
in colonic epithelial cells, goblet cells, macrophages, and
Schwann cells in immunocompetent heterosexual patients with
diarrhea (17). Two recent case study reports of intestinal spi-
rochetes in AIDS patients have demonstrated more severe
inﬂammatory reactions. In one study, spirochetes were re-
ported to be present in intestinal crypts and beyond the mu-
cosa (8). In the second, invasion of spirochetal cells beyond the
brush border epithelium was associated with crypt abscesses
and epithelial ulceration and necrosis (11). Spirochetal inva-
sion of the bile canaliculi, with associated inﬂammation, also
has been observed in an AIDS patient (11). Again, it was
assumed that the spirochetes colonizing these patients be-
longed to B. aalborgi, although this should now be reconsid-
ered in light of the present ﬁndings. Interestingly, crypt absces-
sation and penetration of S. pilosicoli cells through tight
junctions has been observed in the colons of pigs naturally or
experimentally infected with S. pilosicoli (21, 23).
Apart from AIDS patients and homosexual males, the prev-
alence of S. pilosicoli in Western communities is low (14, 20).
To determine the signiﬁcance of S. pilosicoli bacteremia, future
investigations should simultaneously examine fecal and blood
cultures from AIDS and other immunocompromised patients
in Western societies as well as from individuals in developing
communities, where both intestinal carriage and immune de-
ﬁciencies are common. To date, the organism’s low growth
rate, fastidious growth requirements, and failure to provide
growth signals in certain automated blood culture systems may
have prevented it from being isolated more frequently. Further
work is required to improve isolation methods. The animal
models developed to demonstrate the enteropathogenicity of
S. pilosicoli strains (22, 23) also could be used to evaluate their
enteroinvasive capability and their capacity to survive in the
blood and initiate disease in other organ systems. The strains
described here are available for further study.
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